Using funding from CRUK and Psioxus Therapeutics, a team of researchers from the University of Oxford led by Professor Len Seymour, have recently published a paper in Molecular Therapy Oncolytics.
Researchers from the Department of Oncology have been working on creating a therapeutic virus that can be given to cancer patients intravenously. This anti-cancer virus, known as Enadenotucirev, is able to infect and kill cancer cells, while leaving normal cells unharmed.
For the full story on Department of oncology website